Results 261 to 270 of about 10,025,866 (332)
Sex differences in medication discontinuation in axial spondyloarthritis.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or Janus kinase inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we ...
Rachael Stovall +9 more
wiley +1 more source
Representation learning of single-cell time-series with deep variational autoencoders
Fraisse A, Oyarzún DA, Karoui ME.
europepmc +1 more source
A bi-directional cross-channel RNN model for time-series forecasting of dairy production. [PDF]
Naghashi V, Boukadoum M, Diallo AB.
europepmc +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
Antibiotic Use Thresholds for Carbapenem-Resistant Gram-Negative Bacteria: A Nonlinear Time-Series Study. [PDF]
Sun C +5 more
europepmc +1 more source
Objective The purpose was to evaluate a biomarker score consisting of MUC5B rs35705950 promoter variant, plasma matrix metalloproteinase (MMP)‐7, and serum anti‐malondialdehyde‐acetaldehyde (anti‐MAA) antibody for RA‐associated interstitial lung disease risk stratification. Methods Using a multicenter cohort of US veterans with RA, we performed a cross‐
Kelsey Coziahr +16 more
wiley +1 more source
Permutation-Based Distances for Groups and Group-Valued Time Series. [PDF]
Amigó JM, Dale R.
europepmc +1 more source
STF-DKANMixer: Tri-component decomposition with KAN-MLP hybrid architecture for time series forecasting. [PDF]
Wei J, Guo R, Wang Y.
europepmc +1 more source

